Cynomolgus IFN gamma/IFNG Protein, His Tag

YeasenSKU: 95500ES25

Size: 25 ug
Harga:
Harga penjualan$175.00
Saham:
Dalam stok

Product Properties

Alternative Names

IFN-gamma-R1, CDw119, CD119, IFNGR1, IFNGR, AVP, FLJ45734, IFN-gamma R1, IFN-gR1, type 2, IFNγ

Species

Cynomolgus

Expression Sequence

Gln24-Gln165

Accession

P63309

Tag

C-His

Expression System

HEK293

Molecular Weight

The protein has a predicted MW of 17.72 kDa. Due to glycosylation, the protein migrates to 25-35 kDa based on SDS-PAGE result.

Purity

> 95% as determined by SDS-PAGE and HPLC.

Endotoxin

< 1.0 EU per μg by the LAL method.

Formulation

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

Appearance

Lyophilized Powder

Biological Activity

【ELISA Data】 Immobilized Cynomolgus IFN gamma, His Tag at 0.5μg/ml (100μl/well) on the plate. Dose response curve for Human IFNGR1, hFc Tag with the EC50 of 39.4ng/ml determined by ELISA.

Reconstitution Method

Before opening, centrifuge briefly. Reconstitute the lyophilized protein with distilled water to a concentration exceeding 100 μg/mL. Aliquot after initial reconstitution to avoid repeated freeze-thaw cycles.

Features

High purity, high activity, low endotoxin, high batch-to-batch consistency

Storage

Store at -25 to -15°C. Once received, the product is valid for one year. After reconstitution, store under sterile conditions at -85 to -65°C. The product is valid for three months.

Storage

FAQ

Citations

Documents

Applications

Anda mungkin juga menyukai

Pertanyaan

FAQ

Produk ini hanya untuk keperluan penelitian dan tidak ditujukan untuk penggunaan terapeutik atau diagnostik pada manusia atau hewan. Produk dan konten dilindungi oleh paten, merek dagang, dan hak cipta milik Yeasen Bioteknologi. Simbol merek dagang menunjukkan negara asal, belum tentu pendaftaran di semua wilayah.

Aplikasi tertentu mungkin memerlukan hak kekayaan intelektual pihak ketiga tambahan.

Yeasen didedikasikan untuk ilmu etika, meyakini penelitian kami harus menjawab pertanyaan kritis sambil memastikan standar keselamatan dan etika.